Enlarge / A vial of the current Moderna COVID-19 vaccine. (credit: Getty | Ivan Romano) The first doses of omicron-specific COVID-19 vaccines went into the arms of clinical trial participants this week. This takes place just as the towering wave of cases from the ultratransmissible coronavirus variant appears to be cresting in the US and […]
Some claim it’s an “$8 trillion market opportunity.” Read More
Enlarge / Medical Director of the Intensive Care Unit (ICU) checks the vital signs of a COVID-19 patien while her husband rests in a bed next to her at Providence Cedars-Sinai Tarzana Medical Center in Tarzana, California, on January 3, 2021. (credit: Getty | Apu Gomes) Despite its widespread reputation for being mild, the ultratransmissible […]
Accenture CEO Julie Sweet: “We need to act now so that as we deploy at scale, we can act responsibly.” Read More
Enlarge / World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus (credit: Getty | Fabrice Cof) The head of the World Health Organization on Monday dampened optimism that the pandemic will subside in omicron’s wake, noting that global conditions are still ideal for the emergence of new variants. “There are different scenarios for how the pandemic […]
First movers will benefit by reaping profits from the transition, while latecomers will pay an added price. Read More
Columbia’s Glenn Hubbard says more needs to be done to help people who suffer from disruption. Read More
Fortune assembled roughly 100 CEOs yesterday via Zoom for its first CEO meeting of 2022. Read More
Fortune and Deloitte have a new CEO survey out. Read More
The battle for talent continues to be a dominant theme for business in 2022. Read More